Booz Allen Hamilton is rated a conservative 'BUY' reflecting 15x P/E for 2028E. Despite a 40%+ market cap decline and revenue headwinds, BAH delivered strong 4Q26 EPS, a robust $38B backlog, and improved margins. The current valuation under 14-16x P/E is seen as overly discounted given BAH's resilient business model, government client base, and quality metrics.









